Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13) is a small chaperone protein located in the mitochondrial intermembrane space. It forms a complex with TIMM8A, mediating the import and assembly of multi-pass transmembrane proteins, including key components such as TIMM23 and certain solute carrier family members, into the inner mitochondrial membrane. TIMM13 protects precursor proteins from aggregation in the intermembrane space, ensuring their correct targeting and insertion. It is essential for overall mitochondrial integrity and function, with roles in mitochondrial protein import, metabolism, and maintenance of cellular homeostasis. Upregulation of TIMM13 has been linked to tumor cell proliferation and migration in osteosarcoma, making it a proposed novel therapeutic target; defects in TIMM13 or its complex contribute to neurodegenerative diseases such as Mohr-Tranebjaerg syndrome[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13).